We are live on
!
Find out more
NI
Nextech Invest Portfolio holdings
AUM
$1.42B
1-Year Est. Return
304.47%
This Fund
S&P 500
This Quarter
Est. Return
+30.99%
1 Year Est. Return
+304.47%
3 Year Est. Return
+631.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$537M
AUM Growth
+$207M
(+63%)
Cap. Flow
+$120M
Cap. Flow
% of AUM
22.36%
Top 10 Holdings %
Top 10 Hldgs %
98.05%
Holding
17
New
3
Increased
3
Reduced
–
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRGX
CARGO Therapeutics
CRGX
|
+$44.8M |
| 2 |
AMAM
Ambrx Biopharma Inc
AMAM
|
+$35.6M |
| 3 |
Revolution Medicines
RVMD
|
+$35M |
| 4 |
Arvinas
ARVN
|
+$32.9M |
| 5 |
MRSN
Mersana Therapeutics
MRSN
|
+$9.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
+$29.1M |
| 2 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
+$3.26M |
| 3 |
PMV Pharmaceuticals
PMVP
|
+$2.59M |
| 4 |
KRON
Kronos Bio
KRON
|
+$1.89M |
| 5 |
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
|
+$1.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Revolution Medicines
RVMD
$39.1B
| $181M | 33.64% |
6,296,740
+1,457,211
| +30% | +$35M |
|
|
2
Arvinas
ARVN
$534M
| $69.8M | 13% |
1,695,645
+1,408,394
| +490% | +$32.9M |
|
|
CRGX
3
DELISTED
CARGO Therapeutics
CRGX
| $61.2M | 11.4% |
+2,642,502
| New | +$44.8M |
|
4
Tango Therapeutics
TNGX
$4.32B
| $54.8M | 10.21% |
5,533,980
| – | – |
|
|
AMAM
5
DELISTED
Ambrx Biopharma Inc
AMAM
| $44.6M | 8.3% |
+3,129,300
| New | +$35.6M |
|
6
Oric Pharmaceuticals
ORIC
$1.21B
| $39.4M | 7.34% |
4,285,714
| – | – |
|
7
Tyra Biosciences
TYRA
$1.89B
| $34.9M | 6.5% |
2,518,582
| – | – |
|
8
Relay Therapeutics
RLAY
$4.13B
| $14.8M | 2.76% |
1,346,409
+150,000
| +13% | +$1.27M |
|
|
MRSN
9
DELISTED
Mersana Therapeutics
MRSN
| $13.9M | 2.58% |
+239,133
| New | +$9.62M |
|
10
Cullinan Oncology
CGEM
$1.07B
| $12.4M | 2.32% |
1,221,145
| – | – |
|
11
ARS Pharmaceuticals
SPRY
$575M
| $10.5M | 1.95% |
1,910,029
| – | – |
|
12
C4 Therapeutics
CCCC
$401M
| – | – |
-375,857
| Closed | -$699K |
|
|
KRON
13
DELISTED
Kronos Bio
KRON
| – | – |
-1,451,537
| Closed | -$1.89M |
|
|
14
PMV Pharmaceuticals
PMVP
$57.1M
| – | – |
-421,284
| Closed | -$2.59M |
|
|
KNTE
15
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| – | – |
-2,329,480
| Closed | -$3.26M |
|
|
THRX
16
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| – | – |
-611,310
| Closed | -$1.64M |
|
|
EQRX
17
DELISTED
EQRx, Inc. Common Stock
EQRX
| – | – |
-13,104,424
| Closed | -$29.1M |
|
Similar funds
BC
IHG
PTC
PPC
KCMH
APCM
CBA
KC
Nextech Invest's Q4 2023 Portfolio in Review
As of Q4 2023, Nextech Invest held 17 positions worth $537M, up 63% from $330M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Nextech Invest deployed $120M of net new capital in Q4 2023, opening 3 new positions and adding to 3 existing holdings. Its largest new stake was CARGO Therapeutics: 2,642,502 shares worth $61.2M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
On the sell side, the most notable exit was EQRx, Inc. Common Stock, an estimated $29.1M sold.
- Nextech Invest's largest Q4 2023 buy was CARGO Therapeutics: 2,642,502 shares worth $61.2M.
- Nextech Invest added most to Revolution Medicines in Q4 2023, an estimated $35M increase.
- Nextech Invest fully exited EQRx, Inc. Common Stock in Q4 2023, selling an estimated $29.1M.
- Nextech Invest's ten largest holdings make up 98% of its $537M portfolio in Q4 2023.
- Nextech Invest opened 3 new positions and closed 6 in Q4 2023.
- Nextech Invest's portfolio value rose 63% quarter-over-quarter to $537M.
Based on Nextech Invest's 13F filing for Q4 2023, filed 14 Feb 2024.